Výsledky vyhledávání - "Rolando, Vallansot"

Akademický článek

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients

Autor: Natalia Estrada, Blanca Xicoy, Fabian Beier, Olga Garcia, Cristian Morales, Concepción Boqué, Miguel Sagüés, Mónica S. Ventura Ferreira, Rolando Vallansot, Sílvia Marcé, Marta Cabezón, Tim H. Brümmendorf, Lurdes Zamora

Publikováno v: HemaSphere, Vol 5, Iss 12, p e657 (2021)

Tyrosine kinase inhibitors have dramatically changed the outcome of chronic myeloid leukemia (CML), and nowadays, one of the main treatment goals is the achievement of deep molecular responses (DMRs), which can eventually lead to therapy discontinuat

Externí odkaz: https://doaj.org/article/eed0d7528f1d408cb71f85ec9f094861

Zobrazit plný text záznamu

Coexisting Myeloproliferative and Lymphoproliferative Neoplasms: A European Multicenter Retrospective Study

Publikováno v: Blood. 140:12245-12247

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e16eeb06276801c1f9584d53a7d62d8d
https://doi.org/10.1182/blood-2022-168900

Zobrazit plný text záznamu

Thrombogenesis Mechanisms of High Doses of Ponatinib in Patients with Chronic Myeloid Leukemia (CML) Compared to Tyrosine Kinase Inhibitors

Publikováno v: Blood. 140:6730-6732

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fc84df00206528fe606f293ef787d64
https://doi.org/10.1182/blood-2022-163070

Zobrazit plný text záznamu

Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia

Autor: Guillermo Ortí, Valentín García-Gutiérrez, Guiomar Bautista, Francisca Ferrer-Marín, Rolando Vallansot, Blanca Xicoy, Àngela Sánchez, Isabel Simon, Ana Triguero, Magdalena Sierra, Luis Felipe Casado

Publikováno v: Leukemia research. 121

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c82dea32e8ed62b1d83920bcd189bf76
https://pubmed.ncbi.nlm.nih.gov/35933910

Zobrazit plný text záznamu

Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

Autor: Carmen, Martínez, Manuel Espeso, de Haro, Samuel, Romero, Antonio, Gutiérrez, Eva, Domingo-Domènech, Ana P, González-Rodríguez, Izaskun, Zeberio, María Paz, Martínez-Badas, Antonia, Rodríguez-Izquierdo, Cecilia, Carpio, Mariana, Bastos-Oreiro, José Ángel, Hernández-Rivas, Rolando, Vallansot, Nicholas, Kelleher, Francisco J, Díaz-Gálvez, Tamara, Torrado, Arturo, Pereira, Ramón, García-Sanz

Publikováno v: Annals of hematology.

The AETHERA trial demonstrated that brentuximab vedotin (BV) consolidation after autologous stem cell transplantation (ASCT) in patients with Hodgkin lymphoma (HL) at high risk of relapse/progression increases progression-free survival (PFS). Patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7edcd6a0242487700d72dee96eea4c23
https://pubmed.ncbi.nlm.nih.gov/36370191

Zobrazit plný text záznamu

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients

Autor: Marta Cabezón, Cristian Morales, Mónica S. Ventura Ferreira, Natalia Estrada, Rolando Vallansot, Silvia Marcé, Lurdes Zamora, Miguel Sagüés, Concepción Boqué, Fabian Beier, Tim H. Brümmendorf, Olga García, Blanca Xicoy

Publikováno v: Scientia
HemaSphere, Vol 5, Iss 12, p e657 (2021)
HemaSphere
Dipòsit Digital de la UB
Universidad de Barcelona
HemaSphere : open access journal of the European Hematology Association 5(12), e657 (2021). doi:10.1097/HS9.0000000000000657

HemaSphere : open access journal of the European Hematology Association 5(12), e657 (2021). doi:10.1097/HS9.0000000000000657
Published by Wolters Kluwer Health, [Philadelphia, Pennsylvania]

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad32d4a5885bbdc35be5bbc349b82e77
https://hdl.handle.net/11351/9225

Zobrazit plný text záznamu

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Amyloid Arthropathy Associated to Multiple Myeloma

Autor: Julieta Landeyro, Elena Llinares, Aida Sabaté-Llobera, Rolando Vallansot, Cristina Gámez-Cenzano

Publikováno v: JCR: Journal of Clinical Rheumatology. 26:20-23

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28156092688a8c7f9a709f3257752382
https://doi.org/10.1097/rhu.0000000000000768

Zobrazit plný text záznamu

Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Blood Cancer Journal
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
BLOOD CANCER JOURNAL
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Blood Cancer Journal, Vol 8, Iss 10, Pp 1-8 (2018)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Over half of chronic myeloid leukemia (CML) patients in deep molecular response do not lose the major molecular response (MMR) after stopping treatment with tyrosine kinase inhibitors (TKI). This strategy is safe in clinical trials, but its applicabi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e61eb01fd76f85adade1ddbbf6ac59
https://www.nature.com/articles/s41408-018-0125-0.pdf

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání